Determination of Entamoeba histolytica and Entamoeba dispar infection by Enzyme-Linked Immunosorbent Assay (ELISA) and its clinical correlation in pediatric patients

Archives of Medical Research

Volumn 31, Issue 4, 2000, Pages S55-S56

  Bernal, Rosamarı́a ^a   Martı́nez, Laura G ^a   Zepeda, Beatriz ^a   Hernández, Guadalupe ^a   Baer, George M ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b Baer Laboratorio   (Mexico)

Author keywords

Clinic; Diagnosis; Entamoeba histolytica; Laboratory tests

Indexed keywords

ADOLESCENT; AMEBIASIS; ARTICLE; CHILD; CLINICAL ARTICLE; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MALE; NEWBORN;

ANIMALS; CHILD; CHILD, PRESCHOOL; DIGESTIVE SYSTEM; ENTAMOEBA; ENTAMOEBIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; SPECIES SPECIFICITY;

EID: 0033750554     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(00)00180-6     Document Type: Article

References (5)

1. Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin
2. Pathogenic and non-pathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin
3. Amoebiasis